These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15306248

  • 1. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
    Przybyłkowski A, Kurkowska-Jastrzebska I, Joniec I, Ciesielska A, Członkowska A, Członkowski A.
    Brain Res; 2004 Sep 03; 1019(1-2):144-51. PubMed ID: 15306248
    [Abstract] [Full Text] [Related]

  • 2. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 3. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.
    Kurkowska-Jastrzebska I, Bałkowiec-Iskra E, Ciesielska A, Joniec I, Cudna A, Zaremba MM, Członkowski A, Członkowska A.
    Int Immunopharmacol; 2009 Jun 15; 9(6):781-91. PubMed ID: 19286483
    [Abstract] [Full Text] [Related]

  • 4. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
    Ren JP, Zhao YW, Sun XJ.
    Chin Med J (Engl); 2009 Oct 05; 122(19):2366-71. PubMed ID: 20079141
    [Abstract] [Full Text] [Related]

  • 5. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.
    Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybyłkowski A, Członkowski A, Członkowska A.
    Int Immunopharmacol; 2004 Oct 05; 4(10-11):1307-18. PubMed ID: 15313429
    [Abstract] [Full Text] [Related]

  • 6. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 19; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 8. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Joniec I, Ciesielska A, Kurkowska-Jastrzebska I, Przybylkowski A, Czlonkowska A, Czlonkowski A.
    Brain Res; 2009 Mar 19; 1261():7-19. PubMed ID: 19401171
    [Abstract] [Full Text] [Related]

  • 9. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T.
    J Pharmacol Exp Ther; 2007 Jul 19; 322(1):274-81. PubMed ID: 17429058
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 19; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 11. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 19; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 12. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2008 Aug 19; 28(3):610-7. PubMed ID: 18702732
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.
    Chalimoniuk M, Langfort J, Lukacova N, Marsala J.
    Biochem Biophys Res Commun; 2004 Nov 05; 324(1):118-26. PubMed ID: 15464991
    [Abstract] [Full Text] [Related]

  • 14. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K, Inada T, Shingu K.
    Brain Res; 2011 Apr 28; 1387():125-33. PubMed ID: 21376018
    [Abstract] [Full Text] [Related]

  • 15. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 28; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2006 Dec 28; 24(11):3174-82. PubMed ID: 17156378
    [Abstract] [Full Text] [Related]

  • 17. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 18. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S.
    Nat Med; 1999 Dec 24; 5(12):1403-9. PubMed ID: 10581083
    [Abstract] [Full Text] [Related]

  • 19. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
    Zhao Q, Gao J, Li W, Cai D.
    Brain Res; 2010 Jul 30; 1346():224-36. PubMed ID: 20478277
    [Abstract] [Full Text] [Related]

  • 20. Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity.
    Liu B, Xie JX, Tsang LL, Rowlands DK, Ho LS, Gou YL, Chung YW, Chan HC.
    Cell Biol Int; 2008 Jan 30; 32(1):86-92. PubMed ID: 17920944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.